Weston, MA, United States of America

Jeffrey Neal Packman

This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Clementia Pharmaceuticals Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Neal Packman. Retrieved from https://idiyas.com/inventor/jeffrey-neal-packman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey Neal Packman

Introduction

Jeffrey Neal Packman is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of heterotopic ossification. With a total of 5 patents to his name, Packman's work has the potential to improve the quality of life for many patients.

Latest Patents

One of Packman's latest patents focuses on methods for treating heterotopic ossification. This invention features dosing regimens and pharmaceutical formulations for the oral administration of palovarotene. The dosing regimens are designed to reduce heterotopic ossification, decrease the number of flare-ups, and lessen the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva. This innovative approach highlights Packman's commitment to advancing medical treatments.

Career Highlights

Packman is currently associated with Clementia Pharmaceuticals Inc., where he continues to develop groundbreaking therapies. His work at the company underscores his dedication to addressing complex medical challenges through innovative solutions.

Collaborations

Throughout his career, Packman has collaborated with esteemed colleagues, including Clarissa Desjardins and Donna Roy Grogan. These partnerships have likely contributed to the success of his inventions and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Jeffrey Neal Packman is a distinguished inventor whose work in treating heterotopic ossification showcases his innovative spirit and dedication to improving patient outcomes. His contributions to the field of medicine are commendable and reflect the importance of continued research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…